Page last updated: 2024-09-04
xylose and cefixime
xylose has been researched along with cefixime in 2 studies
Compound Research Comparison
Studies (xylose) | Trials (xylose) | Recent Studies (post-2010) (xylose) | Studies (cefixime) | Trials (cefixime) | Recent Studies (post-2010) (cefixime) |
---|---|---|---|---|---|
7,016 | 78 | 2,365 | 866 | 175 | 282 |
7,016 | 78 | 2,365 | 58 | 1 | 18 |
Protein Interaction Comparison
Protein | Taxonomy | xylose (IC50) | cefixime (IC50) |
---|---|---|---|
SUMO-1 | Homo sapiens (human) | 1.48 | |
integrase, partial | Human immunodeficiency virus 1 | 1.8255 | |
lens epithelium-derived growth factor p75 | Homo sapiens (human) | 1.8255 | |
Phospholipase C, gamma 1 | Homo sapiens (human) | 1.212 |
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bouten, A; Carbon, C; Deslandes, A; Duverne, C; Farinotti, R; Trouvin, JH; Westphal, JF | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Other Studies
2 other study(ies) available for xylose and cefixime
Article | Year |
---|---|
Modification of cefixime bioavailability by nifedipine in humans: involvement of the dipeptide carrier system.
Topics: Administration, Oral; Adult; Biological Availability; Biological Transport, Active; Cefixime; Cefotaxime; Dipeptides; Drug Carriers; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Intestinal Absorption; Male; Nifedipine; Sensitivity and Specificity; Xylose | 1992 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |